Formulary Committee Membership Will Be Scrutinized By OIG, Attorney Says
Executive Summary
Physicians who sit on formulary committees may be a focus of heightened scrutiny under the HHS Office of the Inspector General's compliance guide due to possible conflict-of-interest issues